Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03462940 · ClinicalTrials.gov registry record · NA
Effects of TUDCA on Endothelial Function in Type 2 DM
A NA study, sponsored by Boston University.
- Terminated
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT03462940 is a NA study that was terminated before completion, run by Boston University. The registered enrollment target is 2 participants.
The verdict
NCT03462940, a NA study, was terminated before completion, sponsored by Boston University.
- TERMINATED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
The pilot study is designed to investigate the acute and chronic effects of the diet supplement tauroursodeoxycholic acid (TUDCA) on endothelial function in participants with type 2 diabetes mellitus.
Interventions
- DIETARY_SUPPLEMENT Tauroursodeoxycholic acid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2018-04-02 |
| Est. Completion | 2021-02-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03462940
The ClinicalTrials.gov registry entry for NCT03462940 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston University, which has 185 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Tauroursodeoxycholic acid is the first listed.
NCT03462940 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03462940 about?
NCT03462940 is a clinical study titled "Effects of TUDCA on Endothelial Function in Type 2 DM". The pilot study is designed to investigate the acute and chronic effects of the diet supplement tauroursodeoxycholic acid (TUDCA) on endothelial function in participants with type 2 diabetes mellitus.
What is the current status of trial NCT03462940?
This trial is currently terminated. It is a NA study. The enrollment target is 2 participants. The study started on 2018-04-02. Estimated completion is 2021-02-09.
What interventions are being tested in trial NCT03462940?
The interventions under investigation include: Tauroursodeoxycholic acid (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03462940?
This trial is sponsored by Boston University, which has 185 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.